1xbet 모바일 Pharmaceutical Co., Ltd.
1xbet 모바일 Pharmaceutical Co., Ltd. Announces the Appointment of New President
Tokyo, Japan -- 1xbet 모바일 Pharmaceutical Co., Ltd. (Head office: Chiyoda-ku, Tokyo) today announced that the board of directors passed a resolution at its meeting held on June 25, 2008 to appoint Mr. Taro Iwamoto as the new President and Representative Director of 1xbet 모바일 Pharmaceutical Co., Ltd.
Mr. Iwamoto succeeds Mr. Tatsuo Higuchi, who has held the office of President and Representative Director since June, 2000. During his 8-year tenure, Mr. Higuchi led 1xbet 모바일 Pharmaceutical's overseas expansion and strengthened the company's global operations, reinforcing 1xbet 모바일 Pharmaceutical's position as the core company of the 1xbet 모바일 Pharmaceutical Group. As 1xbet 모바일 Pharmaceutical's president and representative director, Mr. Iwamoto, who combines strong leadership with expertise both in international business development and in global R&D, will steer 1xbet 모바일 Pharmaceutical towards further global expansion of both our pharmaceutical and consumer products businesses in line with our objective to become a global value-creating company.
Biography 1xbet 모바일 Newly Appointed President
Name | Taro Iwamoto | |
---|---|---|
Place 1xbet 모바일 Birth | Shizuoka prefecture | |
Date 1xbet 모바일 Birth | August 14, 1960 | |
Biography | November, 1994 | Joined 1xbet 모바일 Pharmaceutical Co., Ltd. |
October, 1998 | GPL (aripiprazole), Development Department, Headquarters 1xbet 모바일 New Drug Evaluation and Development |
|
April, 2004 | Operating 1xbet 모바일ficer, GPL (aripiprazole), Development Department, Headquarters 1xbet 모바일 New Drug Evaluation and Development |
|
February, 2007 | Senior Operating Officer, 1xbet 모바일 Business Division (OPDC) | |
June, 2007 | Executive Operating 1xbet 모바일ficer, Associate General Manager, 1xbet 모바일 Business Division (OPDC) |
|
June, 2008 | President and Representative Director |
- GPL: Global Project Leader
- OAPI: 1xbet 모바일 America Pharmaceutical Inc.
- OPDC: 1xbet 모바일 Pharmaceutical Development and Commercialization Inc.